 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BOSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Inari Medical, Inc. (NASDAQ: NARI) for potential securities law violations. Investors who have lost money in their Inari...

SHAREHOLDER ALERT: Inari Medical Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) ( Inari ), today announced the appointment of Tim Benner as Senior Vice President of U.S. Sales and Dr. Andrew...

Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Inari Medical to replace Callon Petroleum in S&P 600 at open on 4/1

AppFolio to replace Inari Medical in S&P 400 at open on 4/1

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages NARI Investors with Substantial Losses to Contact FirmSAN FRANCISCO, April 01, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc...

Inari Medical, Inc. (NARI) Plummets on News of DOJ Investigation   Hagens Berman

NARI's total volume now sits at 10.1M. The +1.22% price change was insignificant, leaving IBM's price at $47.98...

The volume for Inari Medical stock increased for one day, resulting in a record-breaking daily growth of 824% of the 65-Day Volume Moving Average

A month has gone by since the last earnings report for Inari Medical, Inc. (NARI). Shares have added about 4% in that time frame, outperforming the S&P 500.Will the recent positive trend continue...

Inari Medical (NARI) Up 4% Since Last Earnings Report: Can It Continue?

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now. Visit...

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inari Medical, Inc. (NARI) Investors with Substantial Losses to Contact Firm, NARI Plummets on News of DOJ Investigation   Hagens Berman

This indicator may be signaling NARI's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Inari Medical (NARI, $46.11) entered Uptrend as Momentum indicator ascends above 0 level on Mar 26, 2024

This indicator may be signaling that NARI's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Inari Medical (NARI, $42.39) entered Downtrend as Momentum indicator drops below 0 level on Mar 25, 2024

Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.

Volume (M)	1.23M
52-Wk High	$71.85
52-Wk Low	$39.11

NARI Inari Medical Inc

About

Feed

News

Sentiment

Earnings

Fundamentals